Encompass Health Corp (N:EHC)
Business Focus: Hospitals, Clinics & Primary Care Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 9001 Liberty Pkwy BIRMINGHAM AL 35242-7509 |
| Tel: | N/A |
| Website: | https://www.encompasshealth.com |
| IR: | See website |
| Key People | ||
| Mark J. Tarr President, Chief Executive Officer, Director | Douglas E. Coltharp Chief Financial Officer, Executive Vice President | Barbara A. Jacobsmeyer Chief Executive Officer - Home Health and Hospice |
| Patrick Darby Executive Vice President, General Counsel, Secretary | Edmund M. Fay Senior Vice President, Treasurer | Andrew Baird Senior Vice President - Public Policy, Legislation and Regulations |
| Andrew L. Price Chief Accounting Officer | Elissa Joy Charbonneau Chief Medical Officer | |
| Business Overview |
| Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Encompass Health Corp revenues increased 10% to $4.8B. Net income applicable to common stockholders excluding extraordinary items increased 41% to $361.6M. Revenues reflect Medicare segment increase of 10% to $3.13B, Medicare Advantage segment increase of 19% to $776.1M. Net income benefited from Interest Expense and Amortization of Deb decrease of 20% to $117.3M (expense). |
| Employees: | 22,356 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $10,517M as of Dec 31, 2023 |
| Annual revenue (TTM): | $4,801M as of Dec 31, 2023 |
| EBITDA (TTM): | $1,016M as of Dec 31, 2023 |
| Net annual income (TTM): | $361.60M as of Dec 31, 2023 |
| Free cash flow (TTM): | $207.30M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $2,644M as of Dec 31, 2023 |
| Shares outstanding: | 100,140,031 as of Feb 14, 2024 |
| Index Membership: | S&P 400 Mid Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.